source
- Seaport Therapeutics goes public as obesity drug race heats up and FDA commissioner faces White House scrutinySeaport Therapeutics announced a successful initial public offering, with CEO Daphne Zohar discussing the company’s next steps on the latest Readout LOUD podcast. The episode also highlighted the…
- Analyst doubts gold-based ALS therapy from Clene, calling it ineffectiveAdam Feuerstein, a senior biotech writer, published a piece in his Biotech Scorecard newsletter questioning a new ALS treatment. The company Clene is developing CNM-Au8, which it describes as a hi…